相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy
Annamaria Ruzzo et al.
SCIENTIFIC REPORTS (2019)
Chemotherapy-induced neutropenia and the prognosis of colorectal cancer: a meta-analysis of cohort studies
XiangZhou Tan et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
DPYD genotype-guided dose individualization to improve patient safety of fluoropyrimidine therapy: call for a drug label update
L. M. Henricks et al.
ANNALS OF ONCOLOGY (2017)
Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: Ready for prime time
Carin A. T. C. Lunenburg et al.
EUROPEAN JOURNAL OF CANCER (2016)
A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities
Jean E. Abraham et al.
BMC MEDICINE (2015)
Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
Thomas J. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Chemotherapy-induced neutropenia is associated with prolonged remission duration and survival time in canine lymphoma
S. L. Wang et al.
VETERINARY JOURNAL (2015)
Neutropenia predicts better prognosis in patients with metastatic gastric cancer on a combined epirubicin, oxaliplatin and 5-fluorouracil regimen
Rujiao Liu et al.
ONCOTARGET (2015)
The association between neutropenia and prognosis in stage III colorectal cancer patients receiving adjuvant chemotherapy
T. Sunaga et al.
EUROPEAN JOURNAL OF CANCER CARE (2014)
Chemotherapy-induced neutropenia as a biomarker of survival in advanced ovarian carcinoma: An exploratory study of the Gynecologic Oncology Group
Krishnansu S. Tewari et al.
GYNECOLOGIC ONCOLOGY (2014)
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
H. J. Schmoll et al.
ANNALS OF ONCOLOGY (2012)
Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX
Kohei Shitara et al.
EUROPEAN JOURNAL OF CANCER (2009)
Associations between drug metabolism genotype, chemotherapy pharmacokinetics, and overall survival in patients with breast cancer
WP Petros et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)